Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction.
Oncogene. 2023 Sep;42(37):2725-2736. doi: 10.1038/s41388-023-02785-5. Epub 2023 Aug 7.
Oncogene. 2023.
PMID: 37550562
Free PMC article.
One more step toward treatment of PARP inhibitor-resistant ovarian cancers.
Ray U, Thirusangu P, Shridhar V.
Ray U, et al.
Oncotarget. 2023 Dec 22;14:1034-1035. doi: 10.18632/oncotarget.28545.
Oncotarget. 2023.
PMID: 38147070
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite